|本期目录/Table of Contents|

[1]陈雪英,梁显泉,牛毓茜,等.生长分化因子-15与COPD危险因素的关系研究进展[J].慢性病学杂志,2020,21(04):534-536.
点击复制

生长分化因子-15与COPD危险因素的关系研究进展

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
21
期数:
2020年04期
页码:
534-536
栏目:
综 述
出版日期:
2020-04-28

文章信息/Info

Title:
-
作者:
陈雪英; 梁显泉; 牛毓茜; 何艳; 代颖
贵州省贵阳市第二人民医院呼吸与危重医学科，贵阳 550081
Author(s):
-
关键词:
生长分化因子-15; 慢性阻塞性肺疾病; 进展
Keywords:
-
分类号:
R563.9
DOI:
-
摘要:
生长分化因子-15（GDF-15）是一个具备典型的转化生长因子－β（TGF-β）超家族的构造特征的分泌 蛋白。有研究证明，GDF-15的水平与慢性阻塞性肺疾病（COPD）的发病存在一定的相关性。本研究就GDF-15与COPD发病的危险因素（吸烟、COPD炎症因子、COPD肺动脉高压、COPD并发症）的相关性进行综述。
Abstract:
-

参考文献/References:

[1] Bootcov MR, Bauskin AR, Valenzuela SM,etal. MIC-1, anovel macrophage inhibitory cytoking, is a divergent member of the TGF- beta super family [J]. Proc Natl Acadsci USA,1997(94):11514-11519. [2] Kempf T, Horn-Wichmann R, Brabant G,et al. Circulat-ing Concentrations of growth differentiation factor-15 inap-parently healthy elderly Individuals and patients with chron-ic heart failure as assessed by a new immunoradiometrics and wich assay [J]. Clin Chem, 2007,53(2):284-291. [3] 顾宇英,赵萌涛,宗明,等.上海地区汉族健康人群血清GDF-15 水平分析[J].同济大学学报,2010,31(3):96-99. [4] Skin AR, Brown DA, Kuffner T, et al. Role of macro-phage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer [J]. Cancer Res,2006,66(10):4983-4986． [5] Kempf T, Eden M, Strelau J, et al. The transforming growth factor- super family member growth differentiation factor-15protects the heart from ischemia/reperfusion injury [J]. Circ Res, 2006,98(3):351-360. [6] 张珺,李慧明,叶素惠,等.慢性充血性心力衰竭患者血清生长分 化因子-15测定的临床意义[J].齐齐哈尔医学院学报,2012,33 (14):1850-1851. [7] 于文敏,丁澍,刘培晶.血清GDF-15在急性冠脉综合征早期诊断 和危险分层中的价值[J].江苏医药,2015,41(9):1027-1029． [8] 田伟萌,王华,梁天亚,等.住院心力衰竭患者GDF-15的改变及 相关研究[J].中国医刊,2016,51(2):38-41. [9] Zimmers TA, Jin X, Hstao EC,et al. Growth differen-tiation factor-15/macrophage inhibitors cytokine-1 induc-tion after kidney and lung injury [J]. Shock, 2005,23(6): 543-548. [10] Carstensen M, Herder C, Brunner EJ,et al. Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the WhitehallⅡstudy [J]. Eur J Endocri-nol,2010,162(5):913-917. [11] Lee DH, Yang Y, Lee SJ, et al. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cell by up-regulating the urokinase-type plasminogen activator system [J]. Cancer Res, 2003,63(15):4648-4655. [12] 邓静静,徐爱晖.血清生长分化因子15水平在肺癌的诊断及化疗疗 效评估中的价值研究[J].中国全科医学,2017,20(15):1823-1828. [13] Lopez AD, Shibuya K, Rao C,et al. Chronic obstructive pulmonary disease: current burden and future projections [J]. Eur Respir J,2006(27):397-412. [14] Wang C, Jianying X, Lan Y,et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross- sectional study [J]. Lancet, 2018,391(10131):1706-1717. [15] 何权瀛.慢性阻塞性肺疾病2016观点[M].中国医学临床百家丛 书,2016:14-15. [16] Foronjy R, Wallace A, D’Armiento J. The pharmokinetic limitations of antioxidant treatment for COPD [J]. Pulm-Pharmacol Ther,2008(21):370-379. [17] Qun W, Di J, HongWei C. Cigarette smoke induces growth differentiation factor 15 production in human lunge-pithelial cells: Implication in mucin over-expression [J]. In-nate Immunity,2012,18(4):617-626. [18] Mutlu LC, Altintas N, Aydin M,et al. Growth differenti-ation factor-15 is a novel biomarker predicting acute exac-erbation of chronic obstructive pulmonary disease [J]. In-flammation, 2015,38(5):1805-1813. [19] Miyoung K, Seung-Ick C, KeumJ,et al. Prognostic value of serum growth differentiation factor-15 in patients with chronic obstructive pulmonary disease exacerbation [J]. Tu-berc Respir Dis,2014,77(6):243-250. [20] Freeman M, Martinez H, Todt C,et al. Acute exacerba-tions of chronic obstructive pulmonary disease are associat-ed with decreased CD4 + & CD8 + T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood [J]. Respiratory Research,2015(16):94. [21] 郭庆玲.慢性阻塞性肺疾病患者外周血CD4 ＋和CD8 ＋Ｔ淋巴细胞 和GDF-15水平与其血清炎症因子水平的关系[J].实用医学杂 志,2016,32(4):597-599. [22] Zieliński J, Tobiasz M, Hawrylkiewicz I, et al. Effects of longterm oxygen therapy on pulmonary hemodynamics in COPD patients: a 6 year prospective study [J]. Chest, 1998,113(1):65. [23] Wight JL, LevyeRD, Churg A. Pulmonary hypertension inchronic obstructive pulmonary disease: current theories of patho-genesis and their implication for treatment [J]. Tho-rax, 2005,60(7):605. [24] Santos S, Peinado VI, Ramírez J, et al. Characterization ofpulmonary vascular remodelling in smokers and patients with mild COPD [J]. Eur Res J,2002,19(4):632. [25] Nussbaumer- ochsner Y, Rabe KF. Systemic manifesta-tions of COPD [J]. Chest, 2011,139(1):165. [26] Patel M, Lee J, Baz M,et al. Growth differentiation fac-tor-15 is associated with muscle mass in chronic obstruc-tive pulmonary disease and promotes muscle wasting in vi-vo [J]. J Cachexia Sarcopenia Muscle,2016,7(4):436-448.

备注/Memo

备注/Memo:
基金项目：贵阳市科技计划项目（20161001） 作者简介：陈雪英，本科，主任医师，研究方向：慢性气 道炎症性疾病、呼吸道感染性疾病的临床研究 通信作者：陈雪英，E-mail：2459612551@qq.com
更新日期/Last Update: 2020-04-28